Congenital Heart Disease in Adults

Congenital Heart Disease in Adults

Volumn , Issue , 2008, Pages 1-181

  Popelová, Jana ^a   Oechslin, Erwin ^b   Kaemmerer, Harald ^c   St John Sutton, Martin G ^d   Žáček, Pavel ^e  

^a NA HOMOLCE HOSPITAL   (Czech Republic)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85127948997     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780203091685     Document Type: Book

References (472)

1. Abbott ME. Atlas of Congenital Cardiac Disease. New York: American Heart Association; 1936.
2. Taussig HB. Congenital Malformations of the Heart. New York: Commonwealth Fund; 1947.
3. Perloff JK. Pediatric congenital cardiac becomes a postoperative adult. The changing population of congenital heart disease. Circulation 1973; 47: 606–19.
4. Engle MA, Perloff K. Congenital Heart Disease After Surgery. Yorke Medical Books: New York; 1983.
5. Perloff JK, Child JS. Congenital Heart Disease in Adults. WB Saunders Co: Philadelphia; 1991.
6. Gatzoulis MA, Webb GD, Daubeney PEF. Diagnosis and Management of Adult Congenital Heart Disease. Churchill Livingstone: London; 2003.
7. Niwa K. New Illustrated Textbook of Cardiology. Adult Congenital Heart Disease. Medical View Co Ltd: Tokyo; 2005.
8. Rokitansky C. Die Defecte der Scheidewande des Herzens. Vienne, 1875.
9. Ebstein W. Uber einen sehr seltenen Fall von Insufficienz der Valvula tricuspidalis, bedingt durch eine angeborene hochgradige Missbildung derselben. Arch Anat Physiol 1866; 33: 238.
10. Baillie M. Morbid Anatomy of Some of the Most Important Parts of the Human Body, 2nd edn. London: Johnson and Nicol, 1797.
11. Roesler H. Interatrial septal defect. Arch Intern Med 1934; 54: 339.
12. McManus BM. Patent ductus arteriosus. In: Roberts WC, ed. Adult Congenital Heart Disease. Philadelphia, PA: FA Davis, 1987: 455–76.
13. Fallot A. Contribution á l´anatomie pathologique de la maladie bleue (cyanose cardiaque). Marseille Medical 1888; 25: 418.
14. Roger H. Clinical researches on the congenital communication of the two sides of the heart by failure of occlusion of the interventricular septum. Bull de l´Acad de Méd 1897; 8: 1074.
15. Kaemmerer H, Stern H, Fratz S et al. Imaging in adults with congenital cardiac disease (ACCD). Thorac Cardiovasc Surg 2000; 48: 328–35.
16. Moore P. MRI-guided congenital cardiac catheterization and intervention: The future? Catheter Cardiovasc Interv 2005; 66: 1–8.
17. Fox JM, Bjornsen KD, Mahoney LT, Fagan TE, Skorton DJ. Congenital heart disease in adults: catheterization laboratory considerations. Catheter Cardiovasc Interv 2003; 58: 219–31.
18. Andrews RE, Tulloh RM. Interventional cardiac catheterisation in congenital heart disease. Arch Dis Child 2004; 89: 1168–73.
19. Holzer R, Cao QL, Hijazi ZM. State of the art catheter interventions in adults with congenital heart disease. Expert Rev Cardiovasc Ther 2004; 2: 699–711.
20. Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy. JAMA 1966; 196: 991–2.
21. Kan JS, White RI, Mitchell SE et al. Percutaneous balloon valvuloplasty: A new method for treating congenital pulmonary valve stenosis. N Engl J Med 1982; 307: 540–2.
22. Lababidi Z, Wu RJ, Walls TJ. Percutaneous balloon aortic valvuloplasty: results in 23 patients. Am J Cardiol 1984; 53: 194–7.
23. Lock JE, Bass JL, Amplatz K et al. Balloon dilatation angioplasty of aortic coarctation in infants and children. Circulation 1983; 68: 109–16.
24. Sohn S, Rothman A, Shiota T et al. Acute and follow-up intravascular ultrasound findings after balloon dilatation of coarctation of the aorta. Circulation 1994; 90: 340–7.
25. Yetman AT, Nykanen D, McCrindle BW et al. Balloon angioplasty of recurrent coarctation: a 12-year review. J Am Coll Cardiol 1997; 30: 811–16.
26. Rao PS. Coarctation of the aorta. Curr Cardiol Rep 2005; 7: 425–34.
27. Shah L, Hijazi Z, Sandhu S, Joseph A, Cao QL. Use of endovascular stents for the treatment of coarctation of the aorta in children and adults: Immediate and midterm results. J Invasive Cardiol 2005; 17: 614–18.
28. Porstsmann W, Wierny L, Warnke H. Der verschluss des D.a.p. ohne thorakotomie (1. Mitteiliung). Thoraxchirurgie 1967; 15: 199–203.
29. King TD, Mills NL. Nonoperative closure of atrial septal defects. Surgery 1974; 75: 383–8.
30. Mašura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: Initial human experience. Cathet Cardiovasc Diagn 1997; 42: 388–93.
31. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Trancatheter closure of ventricular septal defects. Circulation 1988; 78: 361–8.
32. Gross RE, Hubbard JP. Surgical ligation of a patent ductus arteriosus. Report of first successful case. JAMA 1939; 112: 729.
33. Kaemmerer H, Meisner H, Hess J, Perloff JK. Surgical treatment of patent ductus arteriosus: A new historical perspective. Am J Cardiol 2004; 94: 1153–4.
34. Crafoord C, Nylin G. Congenital coarctation of aorta and its surgical treatment. J Thor Surg 1945; 14: 347–61.
35. Blalock A, Taussig HB. The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. JAMA 1945; 128: 189.
36. Stephenson LW, John W. Kirklin: Reminiscences of a surgical resident. J Card Surg 2004; 19: 367–74.
37. Senning A. Surgical correction of transposition of the great vessels. Surgery 1959; 45: 966.
38. Mustard WT. Successful two stage correction of transposition of the great vessels. Surgery 1964; 55: 469.
39. Jatene AD, Fontes VF, Paulista PP et al. Successful anatomic correction of transposition of the great vessels: A preliminary report. Arq Bras Cardiol 1975; 28: 461.
40. Yacoub MH, Radley-Smith R, Hilton CJ. Anatomical correction of complete transposition of the great arteries and ventricular septal defect in infancy. Br Med J 1976; 1: 1112–14.
41. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971; 26: 240–8.
42. de Leval MR. The Fontan circulation: What have we learned? What to expect? Pediatr Cardiol 1998; 19: 316–20.
43. van Doorn CA, Marc R de Leval. The Fontan operation in clinical practice: Indications and controversies. Nature Clinical Practice Cardiovascular Medicine 2005; 2: 116–17.
44. de Leval MR, Kilner P, Gewillig M, Bull C. Total cavo-pulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operation. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg 1988; 96: 682–95.
45. Hoffman JIE. Congenital heart disease: Incidence and inheritance. Pediatr Clin North Am 1990; 37: 25–43.
46. Warnes CA, Liberthson R, Danielson GK et al. Task Force 1: The changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001; 37(5): 1170–5.
47. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890–900.
48. Somerville J. Grown-up congenital heart (GUCH) disease: Current needs and provisions of service for adolescents and adults with congenital heart disease in the UK. Report of the British Cardiac Society Working Party. Heart 2002; 88 (Suppl I): 1–14.
49. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: Changing prevalence and age distribution. Circulation 2007; 115: 163–72.
50. Popelová J, Kölbel F, Dostálová P, Voříšová M. Echocardiography in adults with congenital heart disease. Exp Clin Cardiol 1999; 4(2): 89–93.
51. Forfang K. Hemodynamic findings before and after surgery for atrial septal defect of the secundum type in middle-aged patients. Cardiology 1978; 63(1): 14–32.
52. Oelberg DA, Marcotte F, Kreisman H et al. Evaluation of right ventricular systolic pressure during incremental exercise by Doppler echocardiography in adults with atrial septal defect. Chest 1998; 113(6): 1459–65.
53. Kobayashi Y, Nakanishi N, Kosakai Y. Pre- and postoperative exercise capacity associated with hemodynamics in adult patients with atrial septal defect: A retrospective study. Eur J Cardiothorac Surg 1997; 11(6): 1062–6.
54. Vogel M, Berger F, Kramer A, Alexi-Meshkishvili V, Lange PE. Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart 1999; 82(1): 30–3.
55. Popelová J, Hlaváček K, Honěk T, Špatenka J, Kölbel F. Atrial septal defect in adults. Can J Cardiol 1996; 12(10): 983–8.
56. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmias after surgical closure of atrial septal defects in adults. N Engl J Med 1999; 340: 839–46.
57. Therrien J, Dore A, Gersonz W et al. Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the management of adults with congenital heart disease. Part I. Can J Cardiol 2001; 17(9): 940–59.
58. Deandfield J, Thaulow E, Warnes CA et al. ESC Guidelines: Management of Grown-up Congnenital Heart Disease. Eur Heart J 2003; 24: 1034–84.
59. Landzberg MJ, Murphy JR DJ, Davidson Jr WR et al. Organization of delivery systems for adults with congenital heart disease. J Am Coll Cardiol 2001; 37: 1187–93.
60. Inglessis I, Landzberg MJ. Interventional catheterization in adult congenital heart disease. Circulation 2007; 115: 1622–33.
61. Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis; guidelines from the American Heart Association. Circulation 2007; published ahead April 19, 2007.
62. Horstkotte D, Follath F, Gutschik E et al. ESC Guidelines on prevention, diagnosis and treatment of infective endocarditis. Eur Heart J 2004; 00: 1–37 (ESC website only: www.esc.org).
63. Ewert P, Daehnert I, Berger F et al. Transcatheter closure of atrial septal defects under echocardiographic guidance without X-ray: Initial experiences. Cardiol Young 1999; 9(2): 136–40.
64. Mullen MJ, Dias BF, Walker F et al. Intracardiac echocardiography guided device closure of atrial septal defects. J Am Coll Cardiol 2003; 41: 285–92.
65. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997; 42(4): 388–93.
66. Walsh KP, Tofeig M, Kitchiner DJ, Peart I, Arnold R. Comparison of the Sideris and Amplatzer septal occlusion devices. Am J Cardiol 1999; 83(6): 933–6.
67. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: Results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002; 39(11): 1836–44.
68. Chan KC, Godman MJ, Walsh K et al. Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): Multicentre UK experience. Heart 1999; 82(3): 300–6.
69. Arora R, Kalra GS, Singh S et al. Transcatheter closure of atrial septal defect using self-expandable septal occluder. Indian Heart J 1999; 51(3): 289–93.
70. Berger F, Ewert P, Dahnert I et al. Interventional occlusion of atrial septum defects larger than 20 mm in diameter. Z Kardiol 2000; 89(12): 1119–25.
71. Acar P, Saliba Z, Bonhoeffer P, Sidi D, Kachaner J. Assessment of the geometric profile of the Amplatzer and cardioseal septal occluders by three dimensional echocardiography. Heart 2001; 85(4): 451–3.
72. Losay J, Petit J, Lambert V et al. Pecutaneous closure with Amplatzer device is a safe and efficient alternative to surgery in adults with large atrial septal defects. Am Heart J 2001; 142(3): 544–8.
73. Zahn EM, Wilson N, Cutright W, Latson LA. Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation 2001; 104(6): 711–16.
74. Sideris EB, Toumanides S, Macuil B et al. Transcatheter patch correction of secundum atrial septal defects. Am J Cardiol 2002; 89: 1082–6.
75. Omeish A, Hijazi ZM. Transcatheter closure of atrial septal defects in children and adults using the Amplatzer Septal Occluder. J Interv Cardiol 2001; 14(1): 37–44.
76. Chessa M, Carminati M, Butera G. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002; 39: 1061–5.
77. Hill SL, Berul CI, Patel HT et al. Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J Interv Card Electrophysiol 2000; 4(3): 469–74.
78. Vojácek J, Mates M, Popelova J, Pavel P. Perforation of the right atrium and the ascending aorta following percutaneous transcatheter atrial septal closure. Interact CardioVasc Thorac Surg 2005; 4: 157–9.
79. Cooke JC, Gelman JS, Harper RW. Chiari network entanglement and herniation into the left atrium by an atrial septal defect occluder device. J Am Soc Echocardiogr 1999; 12(7): 601–3.
80. Ewert P, Berger F, Nagdyman N et al. Masked left-ventricular restriction in elderly patients with atrial septal defects: A contraindication for closure? Cathetr Cardiovasc Interv 2001; 52(2): 177–80.
81. Ewert P, Berger F, Nagdyman N et al. Acute left heart failure after interventional occlusion of an atrial septal defect. Z Kardiol 2001; 90(5): 362–6.
82. Onorato E, Pera IG, Melzi G, Rigatelli G. Persistent redundant Eustachian valve interfering with Amplatzer PFO occluder placement: Anatomico-clinical and technical implications. Catheter Cardiovasc Interv 2002; 55(4): 521–4.
83. Lambert V, Belli E, Piot JD, Planche C, Losay J. Hemolysis, a rare complication after percutaneous closure of an atrial septal defect. Arch Mal Coeur Vaiss 2000; 93(5): 623–5.
84. Arciprete P, Vosa C, D’Angelo A, Pellegrino A, Cotrufo M. Ostium secundum atrial septal defect: is it a minor cardiac lesion? Ital J Surg Sci 1983; 13: 149–52.
85. Bayer J, Brunner L, Hugel W et al. Acute left heart failure following repair of atrial spetal defects. Its treatment by reopening. Thoraachir Vask Chir 1975; 23: 346–49.
86. Beyer J. Atrial septal defect: acute left heart failure after surgical closure. Ann Thorac Surg 1978; 25: 36–43.
87. Young D. Later results of closure of secundum atrial septal defects in children. Am J Cardiol 1973; 31: 16–22.
88. Berger F, Vogel M, Alexi-Meskishvili V et al. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 1999; 118: 674–80.
89. Oakley C. Heart Disease in Pregnancy, 1st edn. London: BMJ Publishing Group, 1997.
90. Webb GD, Gatzoulis MA. Atrial septal defects in the adults. Recent progress and overview. Circulation 2006; 114: 1645–53.
91. Murphy JG, Gersh BJ, McGoon MD et al. Long-term outcome after surgical repair of isolated atrial septa defect. N Engl J Med 1990; 323: 1645–50.
92. Konstantinides S, Geibel A, Olschewski M et al. A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med 1995; 333: 469–73.
93. Helber U, Baumann R, Seboldt H, Reinhard U, Hoffmeister HM. Atrial septal defect in adults: Cardiopulmonary exercise capacity before and 4 months and 10 years after defect closure. J Am Coll Cardiol 1997; 29(6): 1345–50.
94. Brochu MC, Baril JF, Dore A et al. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation 2002; 106(14): 1821–6.
95. Shah D, Azhar M, Oakley CM, Cleland JGF, Nihoyannopoulos P. Natural history of secundum atrial septal defect in adults after medical or surgical treatment: A historical prospective study. Br Heart J 1994; 71: 224–8.
96. Attie F, Rosas M, Granados N et al. Surgical treatment for secundum atrial septal defects in patients >40 years old. J Am Coll Cardiol 2001; 38(7): 2035–42.
97. Thomson JDR, Aburawi EH, Watterson KG, Van Doorn C, Gibbs JL. Surgical and transcatheter (Amplatzer) closure of atrial septal defects: A prospective comparison of results and cost. Heart 2002; 87(5): 466–9.
98. Hughes ML, Maskell G, Goh TH, Wilkinson JL. Prospective comparison of costs and short term health outcomes of surgical versus device closure of atrial septal defects in children. Heart 2002; 88(1): 67–70.
99. Berger F, Ewert P, Bjornstad PG et al. Transcatheter closure as standard treatment for most interatrial defects: Experience in 200 patients with the Amplatzer Septal Occluder. Cardiol Young 1999; 9(5): 468–73.
100. Brauer VF, Gessner C, Hagendorff A, Pfeiffer D, Wirtz H. A hemodynamically active type II atrial septal defect in a 78-year-old patient. Indications for interventional catheter occlusion? Dtsch Med Wochenschr 2002; 127(1–2): 26–30.
101. Marshall AC, Lock JE. Structural and compliant anatomy of the patent foramen ovale in patients undergoing transcatheter closure. Am Heart J 2000; 140: 303–7.
102. Sievert H, Horvath K, Zadan E et al. Patent foramen ovale closure in patients with transient ischemic attack/stroke. J Interv Cardiol 2001; 14(2): 261–6.
103. Pinto FJ. When and how to diagnose patent foramen ovale. Heart 2005; 91: 438–40.
104. Lechat P, Mas JL, Lascault G et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148–52.
105. Lamy C, Giannesini C, Zuber M et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale. The PFO-ASA study. Stroke 2002; 33: 706–11.
106. Nighoghossian N, Perinetti M, Barthlet M, Adeleine P, Trouillas P. Potential cardioembolic sources of stroke in patients less than 60 years of age. Eur Heart J 1996; 17: 590–4.
107. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005; 112(7): 1063–72.
108. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003; 107: 5–9.
109. Droste DW, Lakemeier S, Wichter T et al. Optimising the technique of contrast transcranial Doppler ultrasound in the detection of rightto-left shunts. Stroke 2002; 33: 2211–16.
110. Inglessis I, Landzberg MJ. Interventional catheterization in adult congenital heart disease. Circulation 2007; 115: 1622–33.
111. Horstkotte D, Follath F, Gutschik E et al. ESC Guidelines on prevention, diagnosis and treatment of infective endocarditis. Eur Heart J 2004; 00: 1–37 (ESC website only: www.esc.org).
112. Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis; guidelines from the American Heart Association. Circulation 2007; published ahead April 19, 2007.
113. Mas JL, Arouizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345(24): 1740–6.
114. Derani JA, Ugurlu BS, Danielson GK et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999; 100 (19, Suppl II): 171–5.
115. Cujec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol 1999; 15(1): 57–64.
116. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: The Laussane study. Neurology 1996; 46: 1301–5.
117. Mohr JP, Thompson JL, Lazar RM et al. Warfarin–aspirin recurrent stroke study group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 34(20): 1444–51.
118. Hung J, Landzberg MJ, Jenkins KJ et al. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of reccurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000; 35(5): 1311–16.
119. Beitzke A, Schuchlenz H, Gamillscheg A, Stein JI, Wendelin G. Catheter closure of the persistent foramen ovale: Mid-term results in 162 patients. J Interv Cardiol 2001; 14(2): 223–9.
120. Windecker S, Wahl A, Chatterjee T et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Longterm risk of recurrent thromboembolic events. Circulation 2000; 101(8): 893–8.
121. Wahl A, Meier B, Haxel B et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001; 57: 1330–2.
122. La Rosee K, Krause D, Becker M et al. Transcatheter closure of atrial septal defects in adults. Practicality and safety of four different closure systems used in 102 patients. Dtsch Med Wochenschr 2001; 126(38): 1030–6.
123. Martin F, Sanchez P, Doherty E et al. Percutanneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002; 106: 1121–6.
124. Rastelli G, Kirklin JW, Titus JL. Anatomic observations on complete form of persistent common atrioventricular canal with special reference to atrioventricular valves. Mayo Clin Proc 1966; 41(5): 296–308.
125. Piccoli GP, Wilkinson JL, Macartney FJ, Gerlis LM, Anderson RH. Morphology and classification of complete atrioventricular defects. Br Heart J 1979; 42(6): 633–9.
126. Freeman SB, Taft LF, Dooley KJ et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 1998; 80(3): 213–17.
127. Lange R, Schreiber C, Gunther T et al. Results of biventricular repair of congenital cardiac malformations: Definitive corrective surgery? Eur J Cardiothorac Surg 2001; 20(6): 1207–13.
128. Crawford FA Jr, Stroud MR. Surgical repair of complete atrioventricular septal defect. Ann Thorac Surg 2001; 72(5): 1621–8; discussion 1628–9.
129. Digilio MC, Marino B, Cicini MP et al. Risk of congenital heart defects in relatives of patients with atrioventricular canal. Am J Dis Child 1993; 147(12): 1295–7.
130. Deanfield J, Thaulow E, Warnes C et al. Task Force on the Management of Grown Up Congenital Heart Disease, European Society of Cardiology; ESC Committee for Practice Guidelines. Management of grown up congenital heart disease. Eur Heart J 2003; 24(11): 1035–84.
131. Bando K, Turrentine MW, Sun K et al. Surgical management of complete atrioventricular septal defects. A twenty-year experience. J Thorac Cardiovasc Surg 1995; 110(5): 1543–52; discussion 1552–4.
132. Masuda M, Kado H, Tanoue Y et al. Does Down syndrome affect the long-term results of complete atrioventricular septal defect when the defect is repaired during the first year of life? Eur J Cardiothorac Surg 2005; 27(3): 405–9. (Epub 2004 Dec 30)
133. Formigari R, Gargiulo G, Picchio FM. Operation for partial atrioventricular septal defect: A forty-year review. J Thorac Cardiovasc Surg 2000; 119(5): 880–9; discussion 889–90.
134. El-Najdawi EK, Driscoll DJ, Puga FJ et al. Operation for partial atrioventricular septal defect: A forty-year review. J Thorac Cardiovasc Surg 2000; 119(5): 880–9.
135. Gerbode F, Hultgren H, Melrose D, Osborn J. Syndrome of left ventricular– right atrial shunt. Successful surgical repair of defect in five cases, with observation of bradycardia on closure. Ann Surg 1958; 148: 433.
136. Therrien J, Dore A, Gersony W et al. Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the management of adults with congenital heart disease. Part I. Can J Cardiol 2001; 17(9): 940–59.
137. Keith JD, Rose V, Collins G, Kidd BSL. Ventricular septal defect. Incidence, morbidity, and mortality in various age groups. Br Heart J 1971; 33(Suppl): 81–7.
138. Campbell M. Natural history of ventricular septal defect. Br Heart J 1971; 33: 246–57.
139. Neumayer U, Stone S, Somerville J. Small ventricular septal defects in adults. Eur Heart J 1998; 19(10): 1573–82.
140. Van der Velde ME, Sanders SP, Keane JF, Perry SB, Lock JE. Transesophageal echocardiographic guidance of transcatheter ventricular septal defect closure. J Am Coll Cardiol 1994; 23(7): 1660–5.
141. Moodie DS. VSD closure device in the setting of adult congenital heart disease. Catheter Cardiovasc Interv 2005; 64(2): 213.
142. Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the Amplatzer muscular VSD occluder: Initial results and technical considerations. Catheter Cardiovasc Interv 2000; 49(2): 167–72.
143. Thanapoulos BD, Tsaoulis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder: Initial clinical applications in children. J Am Coll Cardiol 1999; 33(5): 1395–9.
144. Chessa M, Carminati M, Cao QL et al. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J Invasive Cardiol 2002; 14(6): 322–7.
145. Pesonen E, Thilen U, Sandstorm S et al. Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder device. Scand Cardiovasc J 2000; 34(4): 446–8.
146. Moller JH, Patton C, Varco RL, Lillehei CW. Late results (30 to 35 years) after operative closure of isolated ventricular septal defect from 1954 to 1960. Am J Cardiol 1991; 68: 1491–7.
147. Kidd L, Driscoll DJ, Gersony WM et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation 1999; 87(Suppl I): I-38–I-51.
148. Brauner R, Birk E, Sahar L, Vidbe BA. Surgical management of ventricular septal defect with aortic valve prolapse: Clinical consid -erations and results. Eur J Cardiothorac Surg 1995; 9: 315–19.
149. Otterstad JE, Nitter-Hague S, Myrhe E. Isolated ventricular septal defect in adults. Clinical and haemodynamic findings. Br Heart J 1983; 50: 343–8.
150. Perloff JK. The Clinical Recognition of Congenital Heart Disease, 4th edn. Philadelphia, PA: WB Saunders Company, 1994.
151. Ammash N, Warnes CA. Ventricular septal defect in adults. Ann Intern Med 2001; 135: 812–24.
152. Morris CD, Reller MD, Menashe VD. Thirty year incidence of infective endocarditis after surgery for congenital heart defect. JAMA 1998; 279: 599–603.
153. Li W, Somerville J. Infective endocarditis in the grown-up congenital heart (GUCH) population. Eur Heart J 1998; 19(1): 166–73.
154. Dabizzi RP, Teodori G, Barletta GA et al. Associated coronary and cardiac anomalies in the tetralogy of Fallot. An angiographic study. Eur Heart J 1990; 11: 692–704.
155. Gatzoulis MA, Clark AL, Cullen S, Newman CGH, Redington AN. Right ventricular diastolic function 15 to 35 years after repair of tetralogy of Fallot. Restrictive physiology predicts superior exercise performance. Circulation 1995; 91: 1775–81.
156. Munkhammar P, Cullen S, Jögi P et al. Early age at repair prevents restrictive right ventricular physiology after surgery for tetralogy of Fallot. J Am Coll Cardiol 1998; 32: 1083–7.
157. Perloff JK. The Clinical Recognition of Congenital Heart Disease, 4th edn. Philadelphia, PA: WB Saunders Company, 1994.
158. Gatzoulis MA, Balaji S, Webber SA et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: A multicentre study. Lancet 2000; 356: 975–81.
159. Hazekamp MG, Kurvers MMJ, Schoof PH et al. Pulmonary valve insertion late after repair of Fallot’s tetralogy. Eur J Cardiothorac Surg 2001; 19(5): 667–70.
160. Niwa K, Siu SC, Webb GD, Gatzoulis MA. Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot. Circulation 2002; 106(11): 1374–8.
161. Niwa K. Aortic root dilatation in tetralogy of Fallot long-term after repair – histology of the aorta in tetralogy of Fallot: Evidence of intrinsic aortopathy. Int J Cardiol 2005; 103(2): 117–19.
162. Ishizaka T, Ichikawa H, Sawa Y et al. Prevalence and optimal management strategy for aortic regurgitation in tetralogy of Fallot. Eur J Cardiothorac Surg 2004; 26(6): 1080–6.
163. Daliento L. Total correction of tetralogy of Fallot: Late clinical follow-up. Ital Heart J 2002; 3(1): 24–7.
164. Vetter VL. Arrhythmias in congenital heart disease. In: Crawford MH, Dimarco JP. Cardiology, 1st edn. London: Mosby International Ltd, 2001: 7.21.1–7.21.14.
165. Russo G, Folino AF, Mazzotti E, Rebellato L, Daliento L. Comparison between QRS duration at standard ECG and signal-averaging ECG for arrhythmic risk stratification after surgical repair of tetralogy of fallot. J Cardiovasc Electrophysiol 2005; 16(3): 288–92.
166. Garson A Jr. Ventricular arrhythmias after repair of congenital heart disease: Who needs treatment? Cardiol Young 1991; 1: 177–81.
167. Murphy JG, Gersh BJ, Mair DD et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 1993; 329: 593–9.
168. Harrison DA, Harris L, Siu SC et al. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol 1997; 30(5): 1368–73.
169. Sunakawa A, Shirotani H, Yokoyama T, Oku H. Factors affecting biventricular function following surgical repair of tetralogy of Fallot. Jpn Circ J 1988; 52: 401–10.
170. Schamberger MS, Hurowitz RA. Course of right and left ventricular function in patients with pulmonary insufficiency after repair of tetralogy of Fallot. Pediatr Cardiol 2000; 21: 244–8.
171. Graham TP Jr. Management of pulmonary regurgitation after tetralogy of Fallot repair. Curr Cardiol Rep 2002; 4(1): 63–7.
172. Therrien J, Provost Y, Merchant N et al. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005; 95(6): 779–82.
173. Therrien J, Siu S, McLauglin PR et al. Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: Are we operating too late? J Am Coll Cardiol 2000; 36: 1670–5.
174. Thierren J, Siu SC, Harris L et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001; 103: 2489–94.
175. Discigil B, Derani JA, Puga FJ et al. Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 2001; 121(2): 344–51.
176. Bonhoeffer P, Boudjemline Y, Qureshi SA et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol 2002; 39: 1664–9.
177. Popelová J, Slavík Z, Škovránek J. Are cyanosed adults with congenital cardiac malformation depressed? Cardiol Young 2001; 11: 379–84.
178. Hu DCK, Seward JB, Puga FJ, Fuster V, Tajik AJ. Total correction of tetralogy of Fallot at age 40 years and older: Long-term follow-up. J Am Coll Cardiol 1985; 5: 40–4.
179. Valdes-Cruz LM, Cayre LO. Echocardiographic Diagnosis of Congenital Heart Disease. An Embryologic and Anatomic Approach, 1st edn. Philadelphia, PA: Lippicott-Raven Publishers, 1999.
180. Perloff JK. The Clinical Recognition of Congenital Heart Disease, 4th edn. Philadelphia, PA: WB Saunders Company, 1994.
181. Abbott ME. Coarctation of the aorta of adult type; statistical study and historical retrospect of 200 recorded cases with autopsy: of stenosis or obliteration of descending aortic arch in subjects above age of two years. Am Heart J 1928; 3: 574.
182. Connolly HM, Huston J 3rd, Brown RD Jr et al. Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic resonance angiographic study of 100 patients. Mayo Clin Proc 2003; 78(12): 1491–9.
183. Šámánek M, Goetzová J, Fišerová J, Škovránek J. Differences in muscle blood flow in upper and lower extremities of patients after correction of coarctation of the aorta. Circulation 1976; 54(3): 377–81.
184. Gardiner HM, Celemajer DS, Sorensen KE et al. Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood. Circulation 1994; 89: 1745–50.
185. Guenthard J, Wyler F. Exercise-induced hypertension in the arms due to impaired arterial reactivity after successful coarctation resection. Am J Cardiol 1995; 75: 814–17.
186. Gidding SS, Rocchini AP, Moorehead C, Schork MA, Rosenthal A. Increased forearm vascular reactivity in patients with hypertension after repair of coarctation. Circulation 1985; 71: 495–9.
187. Rees S, Somerville J, Ward C. Coarctation of the aorta: Magnetic resonance imaging in the late post-operative assessment. Radiology 1989; 173: 499–502.
188. Popelová J, Dostálová P, Telekes P, Škovránek J, Belšan T. What is the status of patients operated on for coarctation of the aorta 33 years ago? Cor Vasa 2002; 44(4): 169–74.
189. Kaemmerer H, Oelert F, Bahlmann J et al. Arterial hypertension in adults after surgical treatment of aortic coarctation. Thorac Cardiovasc Surg 1998; 46: 121–5.
190. Tan JL, Babu-Narayan SV, Henein MY, Mullen M, Li W. Doppler echocardiographic profile and indexes in the evaluation of aortic coarctation in patients before and after stenting. J Am Coll Cardiol 2005; 46(6): 1045–53.
191. Chan KC, Dickinson DF, Wharton GA, Gibbs JL. Continuous wave Doppler echocardiography after surgical repair of coarctation of the aorta. Br Heart J 1992; 68: 192–4.
192. Kaemmerer H, Stern H, Fratz S et al. Imaging in adults with congenital cardiac disease (ACCD). Thoracic Cardiovasc Surg 2000; 48: 328–35.
193. Muhler EG, Neuerburg JM, Ruben A et al. Evaluation of aortic coarctation after surgical repair: Role of magnetic resonance imaging and Doppler ultrasound. Br Heart J 1993; 70(3): 290–5.
194. Kaemmerer H. Aortic coarctation and interrupted aortic arch. In: Gatzoulis M, Webb G, Daubeney P, eds. Management of Adult Congenital Heart Disease. New York: Churchill Livingstone, 2003.
195. Parks WJ, Ngo TD, Plauth WJ et al. Incidence of aneurysm formation after dacron patch aortoplasty repair for coarctation of the aorta: Long-term results and assessment utilizing magnetic resonance angiography with three-dimensional surface rendering. J Am Coll Cardiol 1995; 26: 266–71.
196. Pilla CB, Fontes VF, Pedra CA. Endovascular stenting for aortic coarctation. Expert Rev Cardiovasc Ther 2005; 3(5): 879–90.
197. Hager A, Kanz S, Kaemmerer H, Schreiber C, Hess J. COArctation Long-term Assessment (COALA-Study): Incidence of restenosis and hypertension after surgical repair. JACC 2004; 43(5, Suppl A): 31A [A].
198. Clarkson PM, Nicholson MR, Barrat-Boyes BG, Neutze JN, Whitlock RM. Results after repair of coarctation of the aorta beyond infancy: A 10 to 28 year follow-up with particular reference to late systemic hypertension. Am J Cardiol 1983; 51: 1481–8.
199. Kappetein AP, Zwinderman AH, Borges AJJC, Rohmer J, Huysmans HA. More than thirty-five years of coarctation repair. J Thorac Cardiovasc Surg 1994; 107: 87–95.
200. Fišerová J, Šámánek M, Tuo me S, Padovcoá H, Hućín B. Clinical findings and hemodynamic parameters in adults surgically treated for coarctation of aorta in childhood. Cardiology 1980; 65: 205–13.
201. Vriend JW, de Groot E, Bouma BJ et al. Carotid intima–media thickness in post-coarctectomy patients with exercise induced hypertension. Heart 2005; 91(7): 962–3.
202. Cyran SE, Grzesciak M, Kaufman K et al. Aortic ‘recoarctation’ at rest versus at exercise in children as evaluated by stress Doppler echocardiography after a ‘good’ operative result. Am J Cardiol 1993; 71: 963–70.
203. von Kodolitsch Y, Aydin MA, Koschyk DH et al. Predictors of aneurysmal formation after surgical correction of aortic coarctation. J Am Coll Cardiol 2002; 39(4): 617–24.
204. Vriend JW, Drenthen W, Pieper PG et al. Outcome of pregnancy in patients after repair of aortic coarctation. Eur Heart J 2005; 26(20): 2173–8. (Epub 2005 Jun 9).
205. De Bono J, Freeman LJ. Aortic coarctation repair – lost and found: The role of local long term specialised care. Int J Cardiol 2005; 104(2): 176–83.
206. Hager A, Kaemmerer H, Hess J. Comparison of helical CT scanning and MRI in the follow-up of adults with coarctation of the aorta. Chest 2005; 127(6): 2296.
207. Didier D, Saint-Martin C, Lapierre C et al. Coarctation of the aorta: Pre and postoperative evaluation with MRI and MR angiography; correlation with echocardiography and surgery. Int J Cardiovasc Imaging 2005; Nov 3: 1–19.
208. Campbell J. Natural history of coarctation of the aorta. Br Heart J 1970; 32: 633–40.
209. Maron BJ. Aortic isthmic coarctation. In: Roberts WC, ed. Adult Congenital Heart Disease, 1st edn. Philadelphia, PA: FA Davis Co, 1987: 443–53.
210. Brouwer RMHJ, Erasmus ME, Ebels T, Eijgelaar A. Influence of age on survival, late hypertension, and recoarctation in elective aortic coarctation repair. J Thor Cardiovasc Surg 1994; 108(3): 525–31.
211. Bobby JJ, Emami JM, Farmer RDT, Newman CGH. Operative survival and 40 years follow up of surgical repair of aortic coarctation. Br Heart J 1991; 65: 271–6.
212. Presbitero P, Demarie D, Villani M et al. Long term results (15–30 years) of surgical repair of aortic coarctation. Br Heart J 1987; 57: 462–67.
213. Valdes-Cruz Lm, Cayre LO. Echocardiographic Diagnosis of Congenital Heart Disease. An Embryologic and Anatomic Approach, 1st edn. Philadelphia, PA: Lippicott-Raven Publishers, 1999.
214. Redington A, Shore D, Oldershaw P. Congenital heart disease in adults. 1st edn. London: WB Saunders Company, 1994.
215. Perloff JK. The clinical recognition of congenital heart disease, 4th edn. Philadelphia, PA: WB Saunders Company, 1994.
216. Niwa K, Perloff JK, Bhuta SM et al. Structural abnormalities of great arterial walls in congenital heart disease: Light and electron microscopic analysis. Circulation 2001; 103: 393–400.
217. Roberts CS, Roberts WC. Dissection of the aorta associated with congenital malformation of the aortic valve. J Am Coll Cardiol 1991; 17: 712.
218. Hahn R, Roman M, Mogtader AH, Devereux RB. Association of aortic dilatation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol 1992; 19: 283–8.
219. Keane MG, Wiegers SE, Plappert T et al. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. Circulation 2000; 102: 35–9.
220. Nistri S, Sorbo MD, Martin M et al. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart 1999; 82: 19–22.
221. Nkomo VT, Enriquez-Sarano M, Ammash NM et al. Bicuspid aortic valve associated with aortic dilatation. A community based study. Arterioscler Thromb Vasc Biol 2003; 23: 351–6.
222. Cecconi M, Manfrin M, Moraca A et al. Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction. Am J Cardiol 2005; 95: 292–4.
223. Williams JCP, Barrett-Boyes BG, Lowe JB. Supravalvular aortic stenosis. Circulation 1961; 24: 1311–18.
224. Roberts WC. The congenitally bicuspid aortic valve. Am J Cardiol 1970; 26: 72–83.
225. DeFilippi CR, DuWayne MD, Willett L et al. Usefulness of Dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 1995; 75: 191–4.
226. Iung B, Gohlke-Bärwolf C, Tornos P et al. Recommendations on the management of the asymptomatic patients with valvular heart disease. Working group report. Eur Heart J 2002; 23(16): 1253–66.
227. Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 Guidelines for the management of patients with valvular heart disese. J Am Coll Cardiol 2006; 48(3): e1–148.
228. Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease. The task force on the management of valvular heart disease of the European Society of Cardiology. European Heart J 2007; 28: 230–68.
229. Cribier A, Eitchaninoff H, Tron C et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006; 47(6): 1214–23.
230. Walker F. Subvalvar and supravalvar aortic stenosis. In: Gatzoulis MA, Webb GD, Daubeney PEF, eds. Diagnosis and Management of Adult Congenital Heart Disease. Edinburgh: Churchill Livingstone, 2003.
231. Connelly MS, Webb GD, Somerville J et al. Canadian consensus conference on adult congenital heart disease 1996. Can J Cardiol 1998; 14(3): 395–452.
232. Bonow RO, Carabello B, De Leon AC et al. ACC/AHA guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998; 32(5): 1486–588.
233. Otto CM. Valvular Heart Disease. Philadelphia, PA: WB Saunders Company, 1999.
234. Reich O, Tax P, Marek J et al. Long term results of percutaneous balloon valvoplasty of congenital aortic stenosis: Independent predictors of outcome. Heart 2004; 90(1): 70–6.
235. Keane JF, Driscoll DJ, Gersony WM et al. Second natural history study of congenital heart defects: Results of treatment of patients with aortic valve stenosis. Circulation 1993; 87(Suppl I): I-16–I-27.
236. Serraf A, Zoghby J, Lacour-Gayet F et al. Surgical treatment of subaortic stenosis: A seventeen-year experience. J Thorac Cardiovasc Surg 1999; 117(4): 669–78.
237. Erentug V, Bozbuga N, Kirall K et al. Surgical treatment of subaortic obstruction in adolescence and adults: Long-term follow up. J Card Surg 2005; 20(1): 16–21.
238. Paulus WJ. Chronic aortic regurgitation. In: Crawford MH, Di Marco JP, Cardiology, 1st edn. London: Mosby, 2001: 6.11.1–6.11.10.
239. Oakley C. Heart Disease in Pregnancy, 1st edn. London: BMJ Publishing Group, 1997.
240. David TE, Feindel CM, Webb GD et al. Aortic valve preservation in patients with aortic root aneurysm: Results of the reimplantation technique. Ann Thorac Surg 2007; 83(2): S732–5.
241. Wernly JA. Thoracic aorta disease. In: Crawford MH, Di Marco JP, eds. Cardiology, 1st edn. London: Mosby, 2001: 1.12.1–1.12.13.
242. Matherne GP. Aneurysms of the sinus of Valsalva. In: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ, eds. Moss and Adams’ Heart Disease in Infants, Children and Adolescents, 6th edn. Philadelphia, PA: Lippincott, Williams and Wilkins, 2001: 686–8.
243. Shah RP, Ding ZP, Quek SS. A ten-year review of ruptured sinus of Valsalva: Clinico-pathological and echo-Doppler features. Singapore Med J 2001; 42(10): 473–6.
244. Sakakibara S, Konno S. Congenital aneurysm of the sinus of Valsalva: A clinical study. Am Heart J 1962; 63: 708.
245. Cripps T, Pumphrey CW, Parker DJ. Rupture of the sinus of Valsalva during pregnancy. Br Heart J 1987; 57: 490.
246. Kaemmerer H, Oechslin E, Seidel H et al. Marfan syndrome: What internists and pediatric or adult cardiologists need to know. Expert Rev Cardiovasc Ther 2005; 3(5): 891–909.
247. DePaepe A, Devereux RB, Dietz HC et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62(4): 417–26.
248. Erbel R, Alfonso F, Boileau C et al. Diagnosis and management of aortic dissection. Recommendations of the Task Force on Aortic Dissection, European Society of Cardiology. Eur Heart J 2001; 22: 1642–81.
249. Johnston KW, Rutherford RB, Tilson MD et al. Suggested standards for reporting on arterial aneurysms: Subcommittee on reporting standards for arterial aneurysms. J Vasc Surg 1991; 13: 452–8.
250. Meijboom LJ, Timmermans J, Zwinderman A et al. Aortic root growth in men and women with the Marfan’s syndrome. Am J Cardiol 2005; 96: 1441–4.
251. Halpern BL, Char F, Murdoch JL et al. A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment. John Hopkins Med J 1971; 129(3): 123–9.
252. Shores J, Berger KR, Murphy EA et al. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan syndrome. N Engl J Med 1994; 330(19): 1335–41.
253. Svensson LG, Crawford ES, Coselli JS et al. Impact of cardiovascular operation on survival in the Marfan patient. Circulation 1989; 80: I233–42.
254. Gott VL, Cameron DE, Pyeritz RE et al. Composite graft repair of Marfan aneurysm of the ascending aorta: Results in 150 patients. J Card Surg 1994; 9(5): 482–9. 43a.
255. Bentall H, De Bono A. A technique for complete replacement of the ascending aorta. Thorax 1968; 23(4): 338–9.
256. David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg 1992; 103(4): 617–21.
257. David TE. Current practice in Marfan’s aortic root surgery: Reconstruction with aortic valve preservation or replacement? What to do with the mitral valve? J Card Surg 1997; 12(Suppl 2): 147–50.
258. Sarsam MA, Yacoub M. Remodeling of the aortic valve annulus. J Thorac Cardiovasc Surg 1993; 105(3): 435–8.
259. Birks EJ, Webb C, Child A et al. Early and long-term results of a valve-sparing operation for Marfan syndrome. Circulation 1999; 100(Suppl 19): II-29–II-35.
260. DeOliveira NC, David TE, Ivanov J et al. Results of surgery for aortic root aneurysm in patients with Marfan syndrome. J Thorac Cardiovasc Surg 2003; 125(4): 789–96.
261. Nienaber CA, Fattori R, Lund G et al. Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement. N Engl J Med 1999; 340(20): 1539–45.
262. Fleck TM, Hutschala D, Tschernich H et al. Stent graft placement of the thoracoabdominal aorta in a patient with Marfan syndrome. J Thorac Cardiovasc Surg 2003; 125(6): 1541–3.
263. Pyeritz RE. Maternal and fetal complications of pregnancy in the Marfan syndrome. Am J Med 1981; (5): 784–90.
264. Groenink M, Lohuis TAJ, Tijssen JPG et al. Survival and complicationfree survival in Marfan’s syndrome: implications of current guidelines. Heart 1999; 82: 499–504.
265. Murdoch JL, Walker BA, Halpern BL et al. Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 1972; 286(15): 804–8.
266. Silverman DI, Burton KJ, Gray J et al. Life expectancy in the Marfan syndrome. Am J Cardiol 1995; 75(2): 157–60.
267. Gott VL, Greene PS, Alejo DE et al. Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med 1999; 340(17): 1307–13.
268. Gott VL, Pyeritz RE, Cameron DE, Greene PS, Mckusick VA. Composite graft repair of Marfan aneurysms of the ascending aorta: Results in 100 patients. Ann Thorac Surg 1991; 52: 38–45.
269. Kelly DT, Spotnitz HM, Beiser GD, Pierce JE, Epstein SE. Effects of chronic right ventricular volume and pressure loading on left ventricular performance. Circulation 1971; 44: 403.
270. Stenberg RG, Fixler DE, Taylor AL, Corbett JR, Firth BG. Left ventricular dysfunction due to chronic right ventricular pressure overload. Resolution following percutaneous balloon valvuloplasty for pulmonary stenosis. Am J Med 1988; 84: 157.
271. Almeda FQ, Kavinsky CJ, Pophal SG, Klein LW. Pulmonic valvular stenosis in adults: Diagnosis and treatment. Catheter Cardiovasc Interv 2003; 60(4): 546–57.
272. Connelly MS, Webb GD, Somerville J et al. Canadian consensus conference on adult congenital heart disease 1996. Can J Cardiol 1998; 14(3): 395–452.
273. Redington A, Shore D, Oldershaw P. Congenital Heart Disease in Adults, 1st edn. London: WB Saunders Company, 1994.
274. Deanfield J, Thaulow E, Warnes C et al. Management of Grown up Congenital Heart Disease, The task force on the management of grown up congenital heart disease of the European Society of Cardiology. European Heart J 2003; 24: 1035–84.
275. Hayes CJ, Gersony WM, Driscoll DJ et al. Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis. Circulation 1993; 87(Suppl 2): I28–37.
276. Jarrar M, Betbout F, Farhat MB et al. Long-term invasive and noninvasive results of percutaneous balloon pulmonary valvuloplasty in children, adolescents, and adults. Am Heart J 1999; 138(5 Pt 1): 950–4.
277. Sharieff S, Shah-e-Zaman K, Faruqui AM. Short- and intermediateterm follow-up results of percutaneous transluminal balloon valvuloplasty in adolescents and young adults with congenital pulmonary valve stenosis. J Invasive Cardiol 2003; 15(9): 484–7.
278. McCrindle BW. Independent predictors of long-term results after balloon pulmonary valvuloplasty. Circulation 1994; 89: 1751–9.
279. Earing MG, Connolly HM, Dearani JA et al. Long-term follow-up of patients after surgical treatment for isolated pulmonary valve stenosis. Mayo Clin Proc 2005; 80(7): 871–6.
280. Marx GR, Hicks RW, Allen HD et al. Noninvasive assessment of hemodynamic responses to exercise in pulmonary regurgitation after operations to correct pulmonary outflow obstruction. Am J Cardiol 1988; 1: 595–601.
281. Dodge-Khatami A, Kadner A, Berger Md F et al. In the footsteps of Senning: Lessons learned from atrial repair of transposition of the great arteries. Ann Thorac Surg 2005; 79(4): 1433–44.
282. Moons P, Gewillig M, Sluysmans T et al. Long term outcome up to 30 years after the Mustard or Senning operation: A nationwide multicentre study in Belgium. Heart 2004; 90(3): 307–13.
283. Oechslin E, Jenni R. 40 years after the first atrial switch procedure in patients with transposition of the great arteries: Long-term results in Toronto and Zurich. Thorac Cardiovasc Surg 2000; 48(4): 233–7.
284. Roos-Hesselink JW, Meijboom FJ, Spitaels SE et al. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22–29 years). Eur Heart J 2004; 25(14): 1264–70.
285. Wilson NJ, Clarkson PM, Barratt-Boyes BG et al. Long-term outcome after the Mustard repair for simple transposition of the great arteries. 28-year follow-up. J Am Coll Cardiol 1998; 32(3): 758–65.
286. Bolger AP, Gatzoulis MA. Towards defining heart failure in adults with congenital heart disease. Int J Cardiol 2004; 97 (Suppl 1): 15–23.
287. Ebenroth ES, Hurwitz RA. Functional outcome of patients operated for d-transposition of the great arteries with the Mustard procedure. Am J Cardiol 2002; 89(3): 353–6.
288. Moons P, De Bleser L, Budts W et al. Health status, function abilities, and quality of life after the Mustard or Senning operation. Ann Thorac Surg 2004; 77(4): 1359–65.
289. Hechter SJ, Webb G, Fredriksen PM et al. Cardiopulmonary exercise performance in adult survivors of the Mustard procedure. Cardiol Young 2001; 11(4): 407–14.
290. Carrel T, Pfammatter JP. Complete transposition of the great arteries: Surgical concepts for patients with systemic right ventricular failure following intraatrial repair. Thorac Cardiovasc Surg 2000; 48(4): 224–7.
291. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol 2000; 86(10): 1111–16.
292. Gewillig M, Cullen S, Mertens B, Lesaffre E, Deanfield J. Risk factors for arrhythmia and death after Mustard operation for simple transposition of the great arteries. Circulation 1991; 84 (Suppl 5): III187–III92.
293. Balzer DT, Johnson M, Sharkey AM, Kort H. Transcatheter occlusion of baffle leaks following atrial switch procedures for transposition of the great vessels (d-TGV). Catheter Cardiovasc Interv 2004; 61(2): 259–63.
294. Gelatt M, Hamilton RM, McCrindle BW et al. Arrhythmia and mortality after the Mustard procedure: A 30-year single-center experience. J Am Coll Cardiol 1997; 29(1): 194–201.
295. Kammeraad JA, van Deurzen CH, Sreeram N et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol 2004; 44(5): 1095–102.
296. Sun ZH, Happonen JM, Bennhagen R et al. Increased QT dispersion and loss of sinus rhythm as risk factors for late sudden death after Mustard or Senning procedures for transposition of the great arteries. Am J Cardiol 2004; 94(1): 138–41.
297. Burkhart HM, Dearani JA, Williams WG et al. Late results of palliative atrial switch for transposition, ventricular septal defect, and pulmonary vascular obstructive disease. Ann Thorac Surg 2004; 77(2): 464–8; discussion 468–9.
298. Dore A, Houde C, Chan KL et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: A multicenter, randomized, placebo-controlled clinical trial. Circulation 2005; 112(16): 2411–16.
299. Hechter SJ, Fredriksen PM, Liu P et al. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol 2001; 87(5): 660–3, A11.
300. Lester SJ, McElhinney DB, Viloria E et al. Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am J Cardiol 2001; 88(11): 1314–16.
301. Robinson B, Heise CT, Moore JW et al. Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries. Pediatr Cardiol 2002; 23(6): 618–23.
302. Janousek J, Tomek V, Chaloupecky VA et al. Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol 2004; 44(9): 1927–31.
303. Brown SC, Eyskens B, Mertens L et al. Self expandable stents for relief of venous baffle obstruction after the Mustard operation. Heart 1998; 79(3): 230–3.
304. Zrenner B, Dong J, Schreieck J et al. Delineation of intra-atrial reentrant tachycardia circuits after Mustard operation for transposition of the great arteries using biatrial electroanatomic mapping and entrainment mapping. J Cardiovasc Electrophysiol 2003; 14(12): 1302–10.
305. Hornung TS, Derrick GP, Deanfield JE, Redington AN. Transposition complexes in the adult: A changing perspective. Cardiol Clin 2002; 20(3): 405–20.
306. Kirjavainen M, Happonen JM, Louhimo I. Late results of Senning operation. J Thorac Cardiovasc Surg 1999; 117(3): 488–95.
307. Drenthen W, Pieper PG, Ploeg M et al; ZAHARA Investigators. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J 2005; 26(23): 2588–95. (Epub 2005 Aug 25).
308. Guedes A, Mercier LA, Leduc L et al. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries J Am Coll Cardiol 2004; 44(2): 433–7.
309. Siu SC, Sermer M, Colman JM et al; Cardiac Disease in Pregnancy (CARPREG) Investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104(5): 515–21.
310. Kreutzer C, De Vive J, Oppido G et al. Twenty-five-year experience with Rastelli repair for transposition of the great arteries. J Thorac Cardiovasc Surg 2000; 120(2): 211–23.
311. Radford DJ, Stafford G. Pregnancy and the Rastelli operation. Aust NZ J Obstet Gynaecol 2005; 45(3): 243–7.
312. Dearani JA, Danielson GK, Puga FJ, Mair DD, Schleck CD. Late results of the Rastelli operation for transposition of the great arteries. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2001; 4: 3–15.
313. Lalezari S, Hazekamp MG, Bartelings MM, Schoof PH, Gittenberger-De Groot AC. Pulmonary artery remodeling in transposition of the great arteries: Relevance for neoaortic root dilatation. J Thorac Cardiovasc Surg 2003; 126(4): 1053–60.
314. Kampmann C, Kuroczynski W, Trubel H et al. Late results after PTCA for coronary stenosis after the arterial switch procedure for transposition of the great arteries. Ann Thorac Surg 2005; 80(5): 1641–6.
315. Hutter PA, Kreb DL, Mantel SF et al. Twenty-five years’ experience with the arterial switch operation. J Thorac Cardiovasc Surg 2002; 124(4): 790–7.
316. Losay J, Touchot A, Serraf A et al. Late outcome after arterial switch operation for transposition of the great arteries. Circulation 2001; 104 (Suppl 12 1): I121–I126.
317. Williams WG, McCrindle BW, Ashburn DA et al; Congenital Heart Surgeon’s Society. Outcomes of 829 neonates with complete transposition of the great arteries 12–17 years after repair. Eur J Cardiothorac Surg 2003; 24(1): 1–9; discussion 9–10.
318. Rehnstrom P, Gilljam T, Sudow G, Berggren H. Excellent survival and low complication rate in medium-term follow-up after arterial switch operation for complete transposition. Scand Cardiovasc J 2003; 37(2): 104–6.
319. Hovels-Gurich HH, Seghaye MC, Ma Q et al. Long-term results of cardiac and general health status in children after neonatal arterial switch operation. Ann Thorac Surg 2003; 75(3): 935–43.
320. Schwartz ML, Gauvreau K, del Nido P, Mayer JE, Colan SD. Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation 2004; 110 (11 Suppl 1): II128–II132.
321. Hui L, Chau AK, Leung MP, Chiu CS, Cheung YF. Assessment of left ventricular function long term after arterial switch operation for transposition of the great arteries by dobutamine stress echocardiography. Heart 2005; 91(1): 68–72.
322. Therrien J, Gatzoulis M, Graham T et al. Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the Management of Adults with Congenital Heart Disease – Part II. Can J Cardiol 2001; 17(10): 1029–50.
323. Anderson RH. The conduction tissues in congenitally corrected transposition. Ann Thorac Surg 2004; 77(6): 1881–2.
324. Espinola-Zavaleta N, Alexanderson E, Attie F et al. Right ventricular function and ventricular perfusion defects in adults with congenitally corrected transposition: Correlation of echocardiography and nuclear medicine. Cardiol Young 2004; 14(2): 174–81.
325. Dyer K, Graham TP. Congenitally corrected transposition of the great arteries: current treatment options. Curr Treat Options Cardiovasc Med 2003; 5(5): 399–407.
326. Ilbawi MN, DeLeon SY, Backer CL et al. An alternative approach to the surgical management of physiologically corrected transposition with ventricular septal defect and pulmonary stenosis or atresia. J Thorac Cardiovasc Surg 1990; 100: 410.
327. Perloff JK. The Clinical Recognition of Congenital Heart Disease, 4th edn. Philadelphia, PA: WB Saunders Company, 1994.
328. Huhta JC, Danielson GK, Ritter DG et al. Survival in atrioventricular discordance. Pediatr Cardiol 1985; 6: 57–60.
329. Therrien J, Barnes I, Somerville J. Outcome of pregnancy in patients with congenitally corrected transposition of the great arteries. Am J Cardiol 1999; 84(7): 820–4.
330. Presbitero P, Somerville J, Rabajoli F, Stone S, Conte MR. Corrected transposition of the great arteries without associated defects in adult patients: Clinical profile and follow-up. Br Heart J 1995; 74: 57–9.
331. Connelly MS, Liu PP, Williams WG et al. Congenitally corrected transposition of the great arteries in the adult: Functional status and complications. J Am Coll Cardiol 1996; 27: 1238–43.
332. Lundstrom U, Bull C, Wyse RKH, Somerville J. The natural and ‘unnatural’ history of congenitally corrected transposition. Am J Cardiol 1990; 65: 1222–9.
333. Hraska V, Duncan BW, Mayer Jr JE et al. Long-term outcome of surgically treated patients with corrected transposition of the great arteries. J Thorac Cardiovasc Surg 2005; 129(1): 182–91.
334. Krichenko A, Benson LN, Burrows P et al. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 1989; 63: 877–80.
335. Therrien J, Dore A, Gersonz W et al. Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the management of adults with congenital heart disease. Part I. Can J Cardiol 2001; 17(9): 940–59.
336. Perloff JK. The Clinical Recognition of Congenital Heart Disease, 4th edn. Philadelphia, PA: WB Saunders Company, 1994.
337. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation 2006; 114: 1873–82.
338. Sadiq M, Latif F, Ur-Rehman A. Analysis of infective endarteritis in patent ductus arteriosus. Am J Cardiol 2004; 93: 513–15.
339. Harrison DA, Benson LN, Lazzam C et al. Percutaneous catheter closure of the persistently patent ductus arteriosus in the adult. Am J Cardiol 1996; 77: 1094–7.
340. O’Donnel C, Neutze JM, Skinner JR, Wilson NJ. Transcatheter patent ductus arteriosus occlusion: Evolution of techniques and results from the 1990s. J Paediatr Child Health 2001; 37(5): 451–5.
341. Donti A, Formigari R, Bonvicini M et al. Transcatheter closure of the patent ductus arteriosus with new-generation devices: Comparative data and follow-up results. Ital Heart J 2002; 3(2): 122–7.
342. Wang JK, Liau CS, Huang JJ et al. Transcatheter closure of patent ductus arteriosus using Gianturco coils in adolescents and adults. Catheter Cardiovasc Interv 2002; 55(4): 513–18.
343. Faella HJ, Hijazi ZM. Closure of the patent ductus arteriosus with the Amplatzer PDA device: Immediate results of the international clinical trial. Catheter Cardiovasc Interv 2000; 51(1): 50–4.
344. Podnar T, Gavora P, Masura J. Percutaneous closure of patent ductus arteriosus: Complementary use of detachable Cook patent ductus arteriosus coils and Amplatzer duct occluders. Eur J Pediatr 2000; 159(4): 293–6.
345. Thanapoulos BD, Hakim FA, Hiari A et al. Patent ductus arteriosus equipment and technique. Amplatzer duct occluder: intermediateterm follow up and technical considerations. J Interv Cardiol 2001; 14(2): 247–54.
346. Bilkis AA, Alwi M, Hasri S et al. The Amplatzer duct occluder: experience in 209 patients. J Am Coll Cardiol 2001; 37(1): 258–61.
347. Thanapoulos BD, Tsaousis GS, Djukic M et al. Transcatheter closure of high pulmonary artery pressure persistent ductus arteriosus with the Amplatzer muscular ventricular septal occluder. Heart 2002; 87(3): 260–3.
348. Demkow M, Ruzyllo W, Siudalska H, Kepka C. Transcatheter closure of a 16mm hypertensive patent ductus arteriosus with the Amplatzer muscular VSD occluder. Cathater Cardiovasc Interv 2001; 52(3): 359–62.
349. Duke C, Chan KC. Aortic obstruction caused by device occlusion of patent arterial duct. Heart 1999; 82(1): 109–11.
350. Joseph G, Mandalay A, Zacharias TU, George B. Severe intravascular hemolysis after transcatheter closure of a large patent ductus arteriosus using the Amplatzer duct occluder: Successful resolution by intradevice coil deployment. Catheter Cardiovasc Interv 2002; 55(2): 245–9.
351. Godart F, Rodes J, Rey C. Severe haemolysis after transcatheter closure of a patent arterial duct with the new Amplatzer duct occluder. Cardiol Young 2000; 10(3): 265–7.
352. Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis; guidelines from the American Heart Association. Circulation 2007; 116(15): 1736–54.
353. Horstkotte D, Follath F, Gutschik E et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis, executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004; 25(3): 267–76.
354. Dearani JA, O’Leary PW, Danielson GK. Surgical treatment of Ebstein’s malformation: State of the art in 2006. Cardiol Young 2006; 16(Suppl 3): 12–20.
355. Attenhofer Jost CH, Connolly HM, Edwards WD et al. Ebstein’s anomaly – review of a multifaceted congenital cardiac condition. Swiss Med Wkly 2005; 135(19–20): 269–81.
356. Gussenhoven EJ, Stewart PA, Becker EA et al. ‘Offsetting’ of the septal tricuspid leaflet in normal hearts and in hearts with Ebstein’s anomaly. Am J Cardiol 1984; 54: 172.
357. Oechslin E, Buchholz S, Jenni R. Ebstein’s anomaly in adults: Doppler-echocardiographic evaluation. Thorac Cardiovasc Surg 2000; 48(4): 209–13.
358. Inai K, Nakanishi T, Mori Y, Tomimatsu H, Nakazawa M. Left ventricular diastolic dysfunction in Ebstein’s anomaly. Am J Cardiol 2004; 93(2): 255–8.
359. Attenhofer Jost CH, Connolly HM, O’Leary PW et al. Left heart lesions in patients with Ebstein’s anomaly. Mayo Clin Proc 2005; 80(3): 361–8.
360. Celemajer DS, Cullen S, Sullivan ID et al. Outcome in neonates with Ebstein’s anomaly. J Am Coll Cardiol 1992; 19: 1041–6.
361. Furer SK, Gomes JA, Love B, Mehta D. Mechanism and therapy of cardiac arrhythmias in adults with congenital heart disease. Mt Sinai J Med 2005; 72(4): 263–9.
362. Danielson GK, Maloney JD, Devloo RAE. Surgical repair of Ebstein’s anomaly. Mayo Clin Proc 1979; 54: 185–92.
363. Carpentier A, Chauvaud S, Macé L et al. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J Thorac Cardiovasc Surg 1988; 96: 92–101.
364. Chauvaud S, Berrebi A, Attellis N et al. Ebstein’s anomaly repair based on functional analysis. Eur J Cardiovasc Surg 2003; 23(4): 525–31.
365. Dearani JA, Danielson GK. Surgical management of Ebstein’s anomaly in the adult. Semin Thorac Cardiovasc Surg 2005; 17: 148–54.
366. Augustin N, Schmidt-Habelmann P, Wottke M, Meisner H, Sebening F. Results after surgical repair of Ebstein’s anomaly. Ann Thorac Surg 1997; 63: 1650–6.
367. Miyamura H, Kanazawa H, Takahashi Y et al. Long-term results of valve replacement in the right side of the heart in congenital heart disease – comparative study of bioprosthetic valve and mechanical valve. Nippon Kyobu geka Gakkai Zasshi 1990; 38(8): 1298–303.
368. Chauvaud S, Fuzellier JF, Berrebi A et al. Bi-directional cavopulmonary shunt associated with ventriculo and valvuloplasty in Ebstein’s anomaly: Benefits in high risk patients. Eur J Cardiothorac Surg 1998; 13(5): 514–19.
369. Akaishi J, Yamauchi H, Ochi M et al. One and a half ventricle repair for Ebstein’s anomaly. Jpn J Thorac Cardiovasc Surg 2003; 51(12): 665–8.
370. Chen JM, Mosca RS, Altmann K et al. Early and medium-term results for repair of Ebstein’s anomaly. J Thorac Cardiovasc Surg 2004; 127(4): 990–8.
371. Chauvaud SM, Brancaccio G, Carpentier AF. Cardiac arrhythmia in patients undergoing surgical repair of Ebstein’s anomaly. Ann Thorac Surg 2001; 71(5): 1547–52.
372. Kumar AE, Fyler DC, Miettinen OS et al. Ebstein’s anomaly: Clinical profile and natural history. Am J Cardiol 1971; 28: 84–95.
373. Gentles TL, Calder AL, Clarkson PM et al. Predictors of long-term survival with Ebstein’s anomaly of the tricuspid valve. Am J Cardiol 1992; 69: 377–81.
374. Attie F, Rosas M, Rijlaarsdam M et al. The adult with Ebstein’s anomaly. Outcome in 72 unoperated patients. Medicine (Baltimore) 2000; 79(1): 27–36.
375. Uhl HSM. A previously undescribed congenital malformation of the heart: Almost total absence of the myocardium of the right ventricle. Bull Johns Hopkins Hosp 1952; 91: 197–205.
376. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971; 26: 240–8.
377. Kreutzer G, Galindez E, Bono H, De Palma C, Laura JP. An operation for the correction of tricuspid atresia. J Thorac Cardiovasc Surg 1973; 66(4): 613–21.
378. Björk VO, Olin CL, Bjarke BB, Thoren CA. Right atrial–right ven -tricular anastomosis for correction of tricuspid atresia. J Thorac Cardiovasc Surg 1979; 77(3): 452–8.
379. de Leval MR, Kilner P, Gewillig M, Bull C. Total cavo-pulmonary connection: A logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg 1988; 96: 682–95.
380. Bridges ND, Lock JE, Castaneda AR. Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk. Circulation 1990; 82(5): 1681–9.
381. Giannico S, Corno A, Marino B et al. Total extracardiac right heart bypass. Circulation 1992; 86 (5 Suppl): II110–II117.
382. Hager A, Kaemmerer H, Eicken A, Fratz S, Hess J. Long-term survival of patients with univentricular heart not treated surgically. J Thorac Cardiovasc Surg 2002; 123(6): 1214–17.
383. Gewillig M. Ventricular dysfunction of the functionally univentricular heart: Management and outcomes. Cardiol Young 2005; 15 (Suppl 3): 31–4.
384. Khairy P, Poirier N, Mercier LA. Univentricular heart. Circulation 2007; 115: 800–12.
385. Tsang W, Johansson B, Salehian O et al. Intracardiac thrombus in adults with the Fontan circulation. Cardiol Young 2007; 24: 1–6.
386. Suqiyama H, Yoo SJ, Williams W, Benson LN. Characterization and treatment of systemic venous to pulmonary venous collaterals seen after the Fontan operation. Cardiol Young 2003; 13(5): 424–30.
387. Deal BJ, Mavroudis C, Backer CL. Arrhythmia management in the Fontan patient. Pediatr Cardiol 2007; Epub Sep 8.
388. Canobbio MM, Mair DD. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996; 28(3): 763–7.
389. Drenthen W, Pieper PG, Roos-Hesselink JW et al. Pregnancy and delivery in women after Fontan palliation. Heart 2006; 92(9): 1290–4.
390. Connelly MS, Webb GD, Somerville J et al. Canadian consensus conference on adult congenital heart disease 1996. Can J Cardiol 1998; 14(3): 395–452.
391. Giannico S, Hammand F, Amodeo A et al. Clinical outcome of 183 extracardiac Fontan patients: The first 15 years. J Am Coll Cardiol 2006; 47(10): 2065–73.
392. Mitchell ME, Ittenbach RF, Gaynor JW et al. Intermediate outcomes after the Fontan procedure in the current era. J Thorac Cardiovasc Surg 2006; 131(1): 172–80.
393. Ono M, Boething D, Goerler H et al. Clinical outcome of patients 20 years after Fontan operation – effect of fenestration on the late mortality. Eur J Cardiothorac Surg 2006; 30(6): 923–9.
394. D’Udekem Y, Iyengar AJ, Cochrane AD et al. The Fontan procedure: Contemporary techniques have improved long-term outcomes. Circulation 2007; 116 (11 Suppl): 1157–64.
395. Reich O, Chaloupecký V, Hučín B et al. Results of the treatment of congenital heart disease with one ventricle with the method of total cavo-pulmonary connection. Cor Vasa 2001; 43(4): 172–8.
396. Mertens L, Hagler D, Somerville J, Sauer U, Gewillig M. Protein losing enteropathy after the Fontan operation: An international multicenter evaluation. J Thorac Cardiovasc Surg 1998; 115: 1063–73.
397. Therrien J, Warnes C, Daliento L et al. Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the management of adults with congenital heart disease. Part III. Can J Cardiol 2001; 17(11): 1135–58.
398. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease: A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958; 18: 533–47.
399. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy in congenial heart disease: A morphometric approach to pulmonary vascular disease. Circulation 1978; 69: 655–67.
400. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007; 115: 1039–50.
401. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004; 351: 1655–65.
402. McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation 2006; 114: 1417–31.
403. Eisenmenger V. Die angeborenen Defecte der Kammerscheidewand des Herzens. Z Klin Med 1897; 32 (Suppl): 1–28.
404. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 1958; II: 701–9, 755–62.
405. Perloff JK, Rosove MH, Child JS, Wright GB. Adults with cyanotic congenital heart disease: Hematologic management. Ann Intern Med 1988; 109: 406–13.
406. Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol 2004; 97 (Suppl 1): 109–15.
407. Diller GP, Dimopoulos K, Broberg CS et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: A combined retrospective and case-control study. Eur Heart J 2006; 27: 1737–42.
408. Broberg CS, Bax BE, Okonko DO et al. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol 2006; 48: 356–65.
409. Perloff JK. Cyanotic congenital heart disease is a multisystem systemic disorder. Exp Clin Cardiol 1999; 4(2): 77–84.
410. Perloff JK, Latta H, Barsotti P. Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease. Am J Cardiol 2000; 86: 1198–204.
411. Perloff JK. The coronary circulation in cyanotic congenital heart disease. Int J Cardiol 2004; 97 (Suppl 1): 79–86.
412. Chugh R, Perloff JK, Fishbein M, Child JS. Extramural coronary arteries in adults with cyanotic congenital heart disease. Am J Cardiol 2004; 94: 1355–7.
413. Fyfe A, Perloff JK, Niwa K, Child JS, Miner PD. Cyanotic congenital heart disease and coronary artery atherogenesis. Am J Cardiol 2005; 96: 283–90.
414. Daliento L, Somerville J, Presbitero P et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998; 19: 1845–55.
415. Oechslin E, Kiowski W, Schindler R et al. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease. Circulation 2005; 112: 1106–12.
416. Cantor WJ, Harrison DA, Moussadji JS et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 1999; 84(6): 677–81.
417. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol 2000; 86: 1111–16.
418. Niwa K, Perloff JK, Kaplan S, Child JS, Miner PD. Eisenmenger syndrome in adults: Ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol 1999; 34: 223–32.
419. Diller GP, Dimopoulos K, Okonko D et al. Exercise intolerance in adult congenital heart disease: Comparative severity, correlates, and prognostic implication. Circulation 2005; 112: 828–35.
420. Kaemmerer H, Fratz S, Braun SL et al. Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital cardiac disease. Am J Cardiol 2004; 94: 825–8.
421. Silversides CK, Granton JT, Konen E et al. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 2003; 42: 1982–7.
422. Perloff JK, Hart EM, Greaves SM, Miner PD, Child JS. Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. Am J Cardiol 2003; 92: 182–7.
423. Sheehan R, Perloff JK, Fishbein MC, Gjertson D, Aberlee DR. Pulmonary neovascularity: A distinctive radiographic finding in Eisenmenger syndrome. Circulation 2005; 112: 2778–85.
424. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425–36.
425. Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 1996; 28(3): 768–72.
426. Sandoval J, Aguirre JS, Pulido T et al. Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. Am J Respir Crit Care Med 2001; 164: 1682–7.
427. Presbitero P, Somerville J, Stone S et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994; 89: 2673–6.
428. Broberg CS, Uebing A, Cuomo L et al. Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. Heart 2006 Dec 12 (Epub ahead).
429. Gleicher N, Midwall J, Hochberger D, Jaffin H. Eisenmengers´s syndrome and pregnancy. Obstet Gynecol Surv 1975; 34: 721–41.
430. Vogel M, Bauer F, Abdul-Khaliq H, Lange PE. Outcome of pregnancy in patients with Eisenmenger reaction. Cor Vasa 1998; 40(5): K–210.
431. Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis; guidelines from the American Heart Association. Circulation 2007; published ahead April 19, 2007.
432. Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996; 15: 100–5.
433. Hopkins WE. The remarkable right ventricle of patients with Eisenmenger syndrome. Coron Artery Dis 2005; 16: 19–25.
434. Somerville J. How to manage the Eisenmenger syndrome. Int J Cardiol 1998; 63: 1–8.
435. Stoica SC, Perreas K, Sharples LD. Heart-lung transplantation for Eisenmenger’s syndrome: operative risks and late outcomes of 51 consecutive cases from a single institution. J heart Lung Transplant 2001; 20: 173.
436. Perloff JK, Marelli AJ, Miner PD. Risk of stroke in adults with cyanotic congenital heart disease. Circulation 1993; 87(6): 1954–9.
437. Schulze-Neick I, Gilbert N, Ewert R et al. Adult patients with congenital heart disease and pulmonary arterial hypertension: First open prospective multicenter study of bosentan therapy. Am Heart J 2005; 150: 716.
438. Galie N, Beghetti M, Gatzoulis MA et al; Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: A multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006; 114: 48–54.
439. Gatzoulis MA, Beghetti M, Galie N et al; on behalf of the BREATHE-5 Investigators. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 openlabel extension study. Int J Cardiol 2007 Jul 19 (published ahead).
440. Cho JM, Puga FJ, Danielson GK et al. Early and long-term results of the surgical treatment of tetralogy of Fallot with pulmonary atresia, with or without major aortopulmonary collaterals. Thorac Cardiovasc Surg 2002; 124: 70–81.
441. Brooks Jr HST. Two cases of an abnormal coronary artery of the heart arising from the pulmonary artery. J Anat Physiol 1885; 20: 26–9.
442. Bland EF, White PD, Garland J. Congenital anomalies of coronary arteries. Report of unusual case associated with cardiac hypertrophy. Am Heart J 1933; 8: 787–801.
443. Samanek M, Voriskova M. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective bohemia survival study. Pediatr Cardiology 1999; 20: 411–17.
444. Valdes-Cruz LM, Cayre LO. Echocardiographic Diagnosis of Congenital Heart Disease. An Embryologic and Anatomic Approach, 1st edn. Philadelphia, PA: Lippicott-Raven Publishers, 1999.
445. Askenazi J, Nadas AS. Anomalous left coronary artery originating from the pulmonary artery: Report on 15 cases. Circulation 1975; 51: 976–87.
446. Angelini P. Coronary artery anomalies – an entity in search of an identity. Circulation 2007; 115: 1296–305.
447. Alexi-Meshkishvilli V, Berger F, Weng Y, Lange PE, Hetzer R. Anomalous origin of the left coronary artery from the pulmonary artery in adults. J Card Surg 1995; 10: 309–15.
448. Lange R, Vogt M, Horer J et al. Long-term results of repair of anomalous origin of the coronary artery from the pulmonary artery. Ann Thorac Surg 2007; 83(4): 1463–71.
449. Sherwood MC, Rockenmacher S, Colan SD, Geva T. Prognostic significance of clinically silent coronary artery fistulas. Am J Cardiol 1999; 83(3): 407–11.
450. Ogden JA. Congenital anomalies of the coronary arteries. Am J Cardiol 1970; 25: 474–9.
451. Yamanaka O, Hobbs RE. Coronary artery anomalies in 126,595 patients undergoing coronary arteriography. Cathet Cardiovasc Diagn 1990; 21: 28–40.
452. Gillebert C, Van Hoof R, Van De Werf F, Piessens J, De Geest H. Coronary artery fistulas in an adult population. Eur Heart J 1986; 7: 437–43.
453. Hobbs RE, Millit HD, Raghavan PV, Moodie DS, Sheldon WC. Coronary artery fistulae: A ten year review. Clev Clin Q 1982; 49: 191–7.
454. Collins N, Mehta R, Benson L, Horlick E. Percutaneous coronary artery fistula closure in adults: Technical and procedural aspects. Catheter Cardiovasc Interv 2007; 69: 872–80.
455. Armsby LR, Keane JF, Sherwood MC et al. Management of coronary artery fistulae. Patient selection and results of transcatheter closure. J Am Coll Cardiol 2002; 39: 1026–32.
456. Cheung DL, Au WK, Cheung HH, Chiu CS, Lee WT. Coronary artery fistulas: Long-term results of surgical correction. Ann Thorac Surg 2001; 71(1): 190–5.
457. Li D, Wu Q, Sun L et al. Surgical treatment of giant coronary artery aneurysm. J Thorac Cardiovasc Surg 2005; 130: 817–21.
458. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy 1967; 116: 178–222.
459. Kato H. Cardiovascular involvement in Kawasaki disease: Evaluation and natural history. Prog Clin Biol Res 1987; 250: 277–86.
460. Niwa K, Tateno S. Kawasaki’s disease. In: Gatzoulis MA, Webb GD, Daubeney PEF, eds. Adult Congenital Heart Disease. New York: Churchill Livingstone, 2003: 433–9.
461. Shirani J, Roberts WC. Solitary coronary ostium in the aorta in the absence of other major congenital cardiovascular anomalies. J Am Coll Cardiol 1993; 21(1): 137–43.
462. Zuber M, Oechslin E, Jenni R. Echogenic structures in the left atrio - ventricular groove: Diagnostic pitfalls. J Am Soc Echocardiogr 1998; 11: 381–6.
463. Valdes-Cruz LM, Cayre LO. Echocardiographic Diagnosis of Congenital Heart Disease. An Embryologic and Anatomic Approach, 1st edn. Philadelphia, PA: Lippicott-Raven Publishers, 1999.
464. Van Rijen EH, Utens EM, Roos-Hesselink JW et al. Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J 2004; 25: 1605–13.
465. Van Rijen EH, Utens EM, Roos-Hesselink JW et al. Longitudinal development of psychopathology in an adult congenital heart disease cohort. Int J Cardiol 2005; 99: 315–23.
466. Van Rijen EH, Utens EM, Roos-Hesselink JW et al. Psychosocial functioning of the adult with congenital heart disease: A 20–33 years follow-up. Eur Heart J 2003; 24: 673–83.
467. Moons P, Van Deyk K, Marquet K, Raes E et al. Individual quality of life in adults with congenital heart disease: A paradigm shift. Eur Heart J 2005; 26: 298–307.
468. Moons P, Van Deyk K, De Geest S, Gewilling M, Budts W. Is the severity of congenital heart disease associated with the quality of life and perceived health of adult patients? Heart 2005; 91: 1193–8.
469. Moons P, Van Deyk K, De Bleser L et al. Quality of life and health status in adults with congenital heart disease: A direct comparison with healthy counterparts. Eur J Cardiovasc Prev Rehabil 2006; 13: 407–13.
470. Popelová J, Slavík Z, Škovránek J. Are cyanosed adults with congenital cardiac malformation depressed? Cardiol Young 2001; 11: 379–84.
471. Kovacs AH, Sears SF, Saidi AS. Biopsychosocial experiences of adults with congenital heart disease: Review of the literature. Am Heart J 2005; 150: 193–201.
472. Kovacs AH, Silversides C, Saidi A, Sears SF. The role of the psychologist in adult congenital heart disease. Cardiol Clin 2006; 24: 607–18.